Navigation Links
5th International Scientific Symposium on Tourette Syndrome to Focus on Latest Research and Treatment

Rare Opportunity to Benefit from Most Current Findings

BAYSIDE, N.Y., May 28 /PRNewswire-USNewswire/ -- Once every five years the most prestigious and internationally renowned scientists and medical experts on Tourette Syndrome (TS) -- the complex neurological disorder that causes involuntary movements and sounds -- convene to disseminate and share the latest advances and findings about this baffling condition.

As part of its basic mission to identify current research and treatment advances and to facilitate meaningful networking among basic and clinical scientists, the national Tourette Syndrome Association (TSA) is sponsoring the 5th International Scientific Symposium on Tourette Syndrome from June 12-14 at the Downtown Marriott in New York City.

Since the last such Symposium in 2004, numerous advances have been made in both understanding the biological underpinnings as well as the application of new and refined approaches to clinical care. Also, due to the highly complex scientific and treatment issues relevant to TS, the meeting program has been developed specifically to provide information that will be of interest to both basic and clinical researchers as well as allied medical practitioners. Specifically, the Symposium planning committee has chosen a series of program topics designed to set the agenda for future TS research initiatives and also with a view toward improving clinical care.

Among the critical issues to be discussed at this meeting will be the emerging and experimental procedure deep brain stimulation (DBS), the development of animal models and advances in cognitive behavioral therapy for reducing tic symptoms.

The Symposium co-chairs are Peter J. Hollenbeck, Ph.D., Purdue University; Jonathan Mink, M.D., Ph.D., University of Rochester Medical Center and John T. Walkup, Johns Hopkins School of Medicine. The Steering Committee which developed the program schedule is chaired by Kevin Black, M.D., Washington University School of Medicine.

The Symposium faculty will present on genetics, neuroimaging, neuropathology, clinical trials (medication and behavioral), epidemiology, neurophysiology, neuro-immunology and descriptive/diagnostic clinical science. Invited speakers are highly renowned experts from the Centers for Disease Control and Prevention, Harvard University, University College London, Yale University School of Medicine, UCLA, as well as physicians from Israel, Sweden and the Netherlands. Anticipated attendance at the Symposium will exceed 200 national and international registrants.

The TSA Early Career Research Award will be presented to the TSA grant recipient Nicole Calakos, M.D., Ph.D for her work on synaptic and circuit level insights for TS and OCD using mouse models. In addition, the TSA Lifetime Achievement Award will be presented to Joseph Jankovic, M.D., in recognition of his many decades of outstanding contributions to TS research, professional education and clinical care for all people touched by TS.

"The perception of Tourette Syndrome has gone from being a curiosity and considered a very rare disorder to one that is increasingly recognized as being an important neurobehavioral condition," said Dr. Walkup, Johns Hopkins School of Medicine, and the Chair of TSA's national Medical Advisory Board. "Scientific and medical researchers are devoting more and more effort to understanding this unique disorder which has both neurological and psychiatric aspects," he added.

Marked by involuntary movements and vocalizations called tics, Tourette Syndrome is an inherited neurological condition frequently misunderstood and misdiagnosed, affecting more than 200,000 Americans. Founded in 1972, the national Tourette Syndrome Association celebrates 37 years of service to the TS community as the only national, voluntary health organization for people with TS. For more information visit

    Contact: Tracy Colletti-Flynn

SOURCE Tourette Syndrome Association
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. International study strengthens case for daily calcium pill
2. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
3. Australian-led international study shows blood pressure drugs cut death rate in type 2 diabetes
4. LCA Hails International Investigators Studying Lung Cancer
5. Arrow International Urges Shareholders To Vote for Approval of the $45.50 Teleflex Inc. Merger and for the Current Board of Directors
6. PRA International Adds Dr. Susan Stansfield as Executive Vice President
7. Medical Services International Maintains Pace in Second Quarter
8. Clarity Imaging International, Inc. Rolls Out Mobile DEXA Program
9. International Gateway Insurance Brokers Partners With MEDILINQ
10. Tulane University to receive $14M for international HIV/AIDS program
11. International Database Seeks to Boost Treatment of Altitude Sickness
Post Your Comments:
(Date:6/25/2016)... California (PRWEB) , ... June 25, 2016 , ... "With ... fit their specific project," said Christina Austin - CEO of Pixel Film Studios. ... customizable and all within Final Cut Pro X . Simply select a ProHand ...
(Date:6/25/2016)... ... 25, 2016 , ... Dr. Calvin Johnson has dedicated his ... implemented orthobiologic procedures as a method for treating his patients. The procedure is ... to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use to help ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published June 14 ... The article goes on to state that individuals are now more comfortable seeking to ... operations such as calf and cheek reduction. The Los Angeles area medical group, Beverly ...
(Date:6/24/2016)... ... ... Marcy was in a crisis. Her son James, eight, was out of control. Prone to ... , “When something upset him, he couldn’t control his emotions,” remembers Marcy. “If there ... my other children and say he was going to kill them. If we were ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with ... Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Belgium , June 24, 2016 /PRNewswire/ ... announced the appointment of Dr. Edward Futcher ... a Non-Executive Director, effective June 23, 2016.Dr. Futcher ... and Nominations and Governance Committees.  As a non-executive ... provide independent expertise and strategic counsel to VolitionRx ...
(Date:6/23/2016)... Calif. , June 23, 2016 Any dentist ... many challenges of the current process. Many of them do ... of the technical difficulties and high laboratory costs involved. And ... to offer it at such a high cost that the ... it. Dr. Parsa Zadeh , founder of ...
(Date:6/23/2016)... Research and Markets has announced the ... 2016 - Forecast to 2022" report to their offering. ... up to date financial data derived from varied research sources ... with potential impact on the market during the next five ... comprises of sub markets, regional and country level analysis. The ...
Breaking Medicine Technology: